• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, January 14, 2022

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Findings of a study published online ahead of print in the July 2022 issue of The American Journal of Managed Care® were featured in an article published by Pharmacy Times. The study, “Projected US Savings From Biosimilars, 2021-2025,” indicated that projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020—driven primarily by new biosimilar entry. Savings were noted to be $124.5 billion under an upper-bound scenario. The findings were also covered by News Medical Life Sciences.

Related Videos
Tom Kim, chief medical officer, Sound Long-Term Care Management
Dr Yara Abdou
Erika Hamilton, MD
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Related Content
The key takeaways from AAD 2025 include expert insights on topical JAK safety, climate-driven skin challenges, tech innovation, and expanding equitable access in dermatology.

ICYMI: Highlights From AAD 2025

December 25th 2025
Article

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, affordability of classic therapies, and advancing AI in dermatology.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

The Top 5 IVBM Content of 2025

Top 5 Most-Read IVBM Content of 2025

December 24th 2025
Article

From oncology to cardiology, Institute for Value-Based Medicine® conversations highlighted the ways value-based care is reshaping access, equity, and outcomes.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Heart failure deaths among older adults in the U.S. are increasingly occurring at home or in hospice, with persistent disparities by race, sex, and region. | Image credit: @saksit-Adobestock.jpeg

Heart Failure Deaths Shift to Home, Hospice, but Racial Disparities Persist

December 23rd 2025
Article

Heart failure deaths increasingly occur at home or in hospice, but racial, sex, and regional disparities persist in end-of-life care.

Read More

FDA approval with stamp. | Image Credit: Surendra – stock.adobe.com

FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy

December 22nd 2025
Article

The cardiac myosin inhibitor is expected to be available in the US in the second half of January 2026.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.